This document summarizes barriers to opioid monitoring in primary care as presented by Dr. Erin Krebs. Some key barriers include short appointment times that limit monitoring, an assumption that opioids are effective without formally assessing benefits, overconfidence in risk perceptions, and negative attitudes viewing monitoring as "policing" rather than patient care. Implications discussed are formally assessing opioid benefits, addressing expectations and readiness to change, maintaining focus on medication harms rather than patient trustworthiness, and developing systems to support recommended monitoring practices.
1. Barriers to Opioid Monitoring in
Primary Care
Erin E. Krebs, MD, MPH
Minneapolis VA Health Care System
University of Minnesota Medical School
2. Disclosures
I have no financial relationships that may pose a
conflict of interest to disclose
I will not discuss off-label use of drugs, biologics
or medical devices
My work is supported by the VA. The views in
this presentation are mine and do not necessarily
reflect the position or policy of the VA or the US
government
3. Outline
Background—goals and current practice
Specific barriers
Implications for practice
4. Opioid monitoring
Ongoing assessment of benefits/harms of
treatment and adherence to therapy
Primary goal is patient centered – to maximize benefit,
minimize harm for individual patient
Secondary goal is for public health – to minimize
potential harm to others
Tools: regularly scheduled visits, history-taking,
care plans, outcome measures, drug testing, pill
counts, prescription drug monitoring programs,
tracking/documentation of aberrant behaviors
6. Balancing benefits and harms
Symptoms Dependence
Social Mood Tolerance Abuse/
role
Pain relief Uncertain Uncertain addiction
Work
benefits risks Injuries
Hypogonadis
Physica m Sleep
l disorders
activity
Pain hyper-
sensitivity
7. Limitations of monitoring
―Although evidence is limited, the expert panel
concluded that chronic opioid therapy can be an
effective therapy for carefully selected and
monitored patients with chronic noncancer pain.‖
Chou et al., Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. J
Pain 2009;10(2):113-130
8. Limitations of monitoring
―Although evidence is limited, the expert panel
concluded that chronic opioid therapy can be an
effective therapy for carefully selected and
monitored patients with chronic noncancer pain.‖
Most evidence for benefits of opioid monitoring
strategies is low quality or indirect
Chou et al., Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. J
Pain 2009;10(2):113-130
9. Limitations of monitoring
―Although evidence is limited, the expert panel
concluded that chronic opioid therapy can be an
effective therapy for carefully selected and
monitored patients with chronic noncancer pain.‖
Most evidence for benefits of opioid monitoring
strategies is low quality or indirect
Monitoring doesn’t correct for lack of careful patient
selection
Doesn’t address underlying deficiencies in pain
management training and services
Chou et al., Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. J
Pain 2009;10(2):113-130
10. Opioid monitoring in practice
Studies show low use of opioid monitoring
Evidence of risk stratification is mixed
High risk patients receive more recommended
practices
Urine drug testing
Mental health visits
Documentation of adherence assessment
But high risk patients also receive more high risk
practices
Early refills
High opioid doses
Concurrent benzodiazepines
Krebs EK, Pain Med 2011;12: 740–746; Morasco BJ, J Gen Intern Med 2011;26:965–71; Seal
KH, JAMA. 2012;307(9):940-947; Starrels JL, J Gen Intern Med 2011; 26(9):958–64
11. Opioid monitoring in practice
Primary care providers rarely follow
recommendations for monitoring of opioid
effectiveness, harms, and adherence
Why?
12. ―The biggest problem in the whole thing is lack of
time. Typically these are complex people with
multiple problems, and you really could spend the
whole appointment, more than one whole
appointment just talking about this. We have all
these reminders that we have to do, and all the
scripts, and they’re wanting a podiatry
consult, and an eye consult, and you just have to
really sit down and go through a person’s
record, and try to make a rational decision. It’s a
horrible time problem. But I take it very
seriously... What if you do create an opiate
problem for somebody?‖
13. Structure of primary care practice
Short appointment times (15-20 minutes)
Infrequent visits
Heavy burden of non-reimbursed tasks
Competing demands
Complexity of visits and number of clinical tasks per
visit increasing faster than visit duration
Estimated time to accomplish all recommended
preventive services: 7.4 hours/day
One study found patients on chronic opioids received
fewer cancer screenings
Abbo ED, J Gen Intern Med 23(12):2058–65; Buckley DI, Ann Fam Med 2010;8:237-244. Chen MA, J
Gen Intern Med 2010;26:58–63; Dyrbye LN, Arch Intern Med epub 2012; Yarnall KS, Am J Public Health
14. ―For those patients that have a legitimate reason
for wanting to take it and if I can trust them—that
they are not selling, they’re not abusing—and
most of these are older patients of mine, I don’t
have them sign a contract because they never
request early refills, they don’t go to the ER in
between visits to get them, and so there’s no
need for me to do periodic drug screenings and
so forth.‖
15. Confidence in risk perceptions
Many physicians do not monitor adherence when
patients are perceived as low risk
Commonly cited factors: older age, verifiable source of pain,
absence of red flags, ―gestalt‖
Research does not support this selective monitoring
Neither patient report nor physician impression accurately
identifies illicit substance use
Physicians do not accurately perceive opioid misuse
Presence of aberrant behaviors does not discriminate
between patients with and without rx drug use disorder
Good news : Many patients support universal
monitoring, often based on personal experiences
and concerns
Fishbain DA, Clin J Pain 1999; 15:184-91; Fleming MF, J Pain, 2007;8:573-82; Melzer EC, Pain Med
epub 2012; Vijayaraghavan M, J Gen Intern Med 2011;26:412–8.
16. ―I think it’s destructive to a basic patient-doctor
relationship. You’re there to help them and they
can tell you their deepest, darkest secrets, but
yet you’re policing them.‖
17. Negative attitudes about monitoring
Many physicians described opioid monitoring as
being more like policing than doctoring
Focus on trustworthiness of patient
Conflict with patient-centered care
Good news: Most patients did not view opioid
monitoring this way
Patients viewed opioids as dangerous drugs (causing
addiction, interacting with other substances)
Patients wanted physicians to focus on their safety
18. ―I usually don't have to ask them if their pain is
under good control. Most of them will come to
me with their concerns.‖
19. A quick poll
Please take a moment to think of the last patient
for whom you wrote an opioid renewal
prescription…
How confident are you the patient is
experiencing substantial benefit that is clearly
outweighing adverse effects?
Highly confident
Somewhat confident
Not at all confident
20. Assumption of effectiveness
Several patients, but no physicians, mentioned
lack of effectiveness as a reason to discontinue
opioids
Discontinuations/tapers were initiated by patients
Some patients continued opioids without benefit
Reasons: doctor’s advice, belief they would be worse
off without it (supported by experience with brief
withdrawals), belief that higher dose/stronger medicine
was needed
Assessing benefit is harder than it sounds, but is
the most important task of opioid monitoring
In the absence of benefit, no risk is acceptable
21. Cycle of ineffective opioid use
Persistent
pain/distress
Unmet
Help-seeking
expectations
+/- physical
dependence
Physician
response
Opioid
22. Cycle of ineffective opioid use
Persistent
pain/distress
Unmet
Help-seeking
expectations
+/- physical
dependence
Physician
response
Opioid
23. Cycle of ineffective opioid use
Persistent
pain/distress
Unmet
Help-seeking
expectations
+/- physical
dependence
Physician
response
Opioid
24. Cycle of ineffective opioid use
Persistent
pain/distress
Unmet
Help-seeking
expectations
+/- physical
dependence
Physician
response
Opioid
25. Cycle of ineffective opioid use
Persistent
pain/distress
Unmet
Help-seeking
expectations
+/- physical
dependence
Physician
response
Opioid
27. Implications for practice
Assumption of effectiveness
Patients starting opioids
See principles
Patients on established long-term opioid therapy
Ask about pain, invest time in listening
Assess opioid expectations, concerns, and
experiences
Provide education on evolving opioid evidence
Address readiness for change at each visit
28. Implications for practice
Negative attitudes about monitoring
Maintain focus on benefits and harms of
medication, rather than trustworthiness of patient
Consider broad differential diagnosis for aberrant
behaviors
Read and recommend:
Nicolaidis C. Pain Med 2011; 12: 890–897
29. Implications for practice
Confidence in risk perceptions
Train entire care team about harms
Educate patients about harms
Make it easier to do the right thing (see below)
Structure of primary care
Develop systems
Institute clinic and facility-level protocols
An oversimplified view of benefits and harms that is commonly presented
A more reality-based depiction of benefits and harms.
This is a summary statement from the APS/AAPM guidelines. I’d like to draw attention to a couple of points:-evidence is limited. -careful pt selection. Pts with conditions that are unlikely to respond, with high risk of harm, without established longitudinal relationshipOpioid monitoring doesn’t address underlying deficiencies… Not a substitute for comprehensive pain management plan. Many frustrations with opioid prescribing may result from relying too heavily on opioids
This is a summary statement from the APS/AAPM guidelines. I’d like to draw attention to a couple of points:-evidence is limited. -careful pt selection. Pts with conditions that are unlikely to respond, with high risk of harm, without established longitudinal relationshipOpioid monitoring doesn’t address underlying deficiencies… Not a substitute for comprehensive pain management plan. Many frustrations with opioid prescribing may result from relying too heavily on opioids
This is a summary statement from the APS/AAPM guidelines. I’d like to draw attention to a couple of points:-evidence is limited. -careful pt selection. Pts with conditions that are unlikely to respond, with high risk of harm, without established longitudinal relationshipOpioid monitoring doesn’t address underlying deficiencies… Not a substitute for comprehensive pain management plan. Many frustrations with opioid prescribing may result from relying too heavily on opioids
We know it isn’t because they are unconcerned about opioid prescribing—many surveys have shown that PCPs are concerned about opioid prescribing and often uncomfortable with it. I don’t believe it is due to lack of awareness of guidelines either—opioid monitoring is a complex task, so simple reminders, incentives, or guideline dissemination are unlikely to be effective. I’m going to focus on four key barriers to improved opioid monitoring—this isn’t a comprehensive review of all barriers, but a discussion of several I think are particularly relevant based on literature, my research, and my own experience as a primary care physician. To illustrate the barriers, I’ll present you with some physician quotes from semistructured interviews on this topic.
This physician was specifically reacting to the one page model opioid agreement from VA guidelines.
Singing to the choir… but these factors are not evident to many well meaning experts and policy makers.
This represents a common sentiment among physicians in our interviews. Only a few disagreed—saying it was impossible to tell who would have trouble.
Neither patient report nor physician impression accurately identify illicit substance use—studies comparing patient and physician report to drug testingPhysicians do not accurately perceive opioid misuse—study comparing physician impression with patient report of misuseAberrant drug related behaviors do not discriminate between patients with and without rx drug use disorder—ADRB can be associated with many factors (dysfunctional coping, social chaos, etc); PDUD can occur without ADRB
This physician is talking about drug testing.
We asked “how do you define a good response to opioid therapy?” A striking finding was that few actively assessed effectiveness and several stated that they assumed a lack of complaints indicated that the opioids were working. This is important considering that only a minority of patients with chronic pain can be expected have a significant clinical response to opioids while most with long term use will develop physical dependence. Many patients also had a hard time describing specific benefits of therapy.
We don’t have much existing literature on this issue, so I’m going to quickly survey those of you in the audience who prescribe opioids in primary care.I’m not asking this to judge your practice, but to illustrate that assessing effectiveness of opioid therapy is harder than it sounds, even for us, in this relatively expert group. Now another question, but I won’t ask for hands. If you are not confident that benefit is outweighing risk, are you discontinuing the medication?
Steady state where opioids are continued without discussion or reevaluation. Pt resigned to poor pain control, but believing she would be worse off without them and physician resigned to continuing opioids but not feeling too bad about it as long as patient isn’t requesting early refills or dose escalations.
Key points to intervene are when starting opioid therapy and when monitoring response and re-evaluating therapy